Gan & Lee Pharmaceuticals.

Quick facts

Marketed products

• Dupilumab Injection

Phase 3 pipeline

• Bempedoic Acid Tablet · Rheumatology / Metabolic Disease
  Bempedoic acid inhibits AMPK-activated protein kinase to reduce uric acid production and lower serum uric acid levels.
• GZR18 · Diabetes
  GZR18 is a long-acting basal insulin analog designed to provide sustained glucose control in diabetes.
• Semaglutide(Wegovy® ) · Diabetes
  Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the natural hormone GLP-1 to regulate blood sugar levels.

Phase 2 pipeline

• GZR101-80
• GZR102

Phase 1 pipeline

• GLR2037
• GZR18 injection A
• GZR18 injection B

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Gan & Lee Pharmaceuticals. portfolio CI brief
• Gan & Lee Pharmaceuticals. pipeline updates RSS